Patent Licensing USA - Conference, Washington DC, June 20

Patent Licensing USA

June 21, 2023

Washington DC

Effective & Practical Strategies for the Patent Licensing Lifecycle

Registration closes in:

DAYS

HOURS

MINUTES

SECONDS

150+

Attendees

20+

Speakers

Hours Content

Bloom Energy and Miles & Stockbridge join the programme for Patent Licensing USA!

Unlock key considerations in monetization and licensing strategy for patent owners.

Patent monetization is a key theme throughout the conference, and we're pleased to announce Thomas Hassing, Vice President of Intellectual Property at Bloom Energy, and Andrew Wahba, Principal at Miles & Stockbridge have just joined the speaker faculty to take a deep dive into the key considerations in monetization and licensing strategy for patent owners.

Andrew and Thomas join an outstanding lineup of speakers from a great range of patent-owning companies and licensing practitioners including:

Amanda Brock

CEO

OpenUK

Kayleigh Nauman

IP Attaché - Trade and Agriculture

British Embassy, Washington, DC

Kelly Morgan

VP, Head of IP and Legal

Arbor Biotechnologies

Nicole Spence

Counsel, Data and AI

IBM Corporation

Paul Coletti

VP, MedTech IP Strategy

Johnson & Johnson

Peng Sun

Senior Director, Senior Patent Counsel

Sarepta Therapeutics

Elaine Drager

Strategic Partnerships and Technology Leadership Office Lead Counsel

Nokia

Brian Hinman

Chief Commercial Officer

Aon

Jaime Siegel

Head of Global Licensing

Open Invention Network

Ken Corsello

US Trade Secrets Counsel / Patent Licensing Counsel

IBM Corporation

Tulip Mahaseth

Associate Director, Intellectual Property & Corporate Counsel

4D Molecular Therapeutics

Saira Haider

Global Intellectual Property Lead Counsel, VP

Therabody

Andrew Wahba

Principal

Miles & Stockbridge

Margaret Sampson

Partner

McDermott Will & Emery

Richard Berman

Partner

ArentFox Schiff

Joe Mahoney

Partner

Mayer Brown

Join The Conversation! #PatentLicensingUSA

What’s different about Patent Licensing USA?

Patent Licensing USA covers the whole licensing agreement lifecycle—in one place and over the course of just one day.

It focuses purely on patent licensing—so every single session is relevant to patent licensing attorneys.

At least half of our delegates are in-house counsel from tech, pharma and biotech companies, enabling real collaboration between in-house and private practice licensing attorneys.